Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2017 11:29 ET | Source: Jubilant DraxImage

Jubilant DraxImage receives approval from Health Canada for the RUBY Elution System™ (RbES) and proprietary RUBY™ Consumable Accessories

Montreal, QC, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma whollyowned subsidiary, is pleased to announce it has received approval from Health Canada...
October 30, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At the Rodman and Renshaw 10th Annual Healthcare Conference On Monday, November 10, 2008

CHARLOTTE, N.C., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference at 3:40...
September 16, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At the UBS Global Life Sciences Conference On Monday, September 22, 2008

CHARLOTTE, N.C., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the UBS Global Life Sciences Conference at 11:00 AM on Monday,...
October 17, 2005 02:19 ET | Source: Antisoma plc

Antisoma Announces Promising Preliminary Phase II Data for AS1404 in Lung Cancer

LONDON, Oct. 17, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma (LSE:ASM) today announces preliminary findings from an ongoing phase II trial of AS1404 in lung cancer. With initial data...
January 07, 2005 02:08 ET | Source: Crucell N.V.

Crucell Announces Evaluation by Genentech of STAR(TM) Technology

LEIDEN, The Netherlands, Jan. 7, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Genentech, Inc. (NYSE:DNA) is currently evaluating...